Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 3.00 | 99.25 | 0.0302 | -0.7851 | |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 2.00 | 99.25 | 0.0202 | -0.8340 | |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 2.00 | 99.25 | 0.0202 | -0.8340 | |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 2.00 | 99.25 | 0.0202 | -0.8340 | |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 2.00 | 99.25 | 0.0202 | -0.8340 | |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 2.00 | 99.25 | 0.0202 | -0.8340 | |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 121.00 | 99.25 | 1.2191 | 1.2693 | |
| SK-BR-3 | 17-AAG | 3.1623 | uM | 7 | 156.25 | 33.46 | 52.00 | 99.25 | 0.5239 | 0.3246 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 156.25 | 33.46 | 120.00 | 99.25 | 1.2091 | 1.2573 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 7 | 156.25 | 33.46 | 106.00 | 99.25 | 1.0680 | 1.0857 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 7 | 156.25 | 33.46 | 114.00 | 99.25 | 1.1486 | 1.1847 |
| SK-BR-3 | Lapatinib | 10 | uM | 7 | 156.25 | 33.46 | 75.00 | 99.25 | 0.7557 | 0.6729 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 7 | 156.25 | 33.46 | 93.00 | 99.25 | 0.9370 | 0.9188 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 7 | 156.25 | 33.46 | 98.00 | 99.25 | 0.9874 | 0.9839 |
| SK-BR-3 | Lapatinib | 1 | uM | 7 | 156.25 | 33.46 | 106.00 | 99.25 | 1.0680 | 1.0857 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 7 | 156.25 | 33.46 | 111.00 | 99.25 | 1.1184 | 1.1479 |
| SK-BR-3 | Erlotinib | 10 | uM | 7 | 156.25 | 33.46 | 66.00 | 99.25 | 0.6650 | 0.5420 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 7 | 156.25 | 33.46 | 84.00 | 99.25 | 0.8464 | 0.7982 |
| SK-BR-3 | 17-AAG | 0.0016596 | uM | 7 | 156.25 | 33.46 | 122.00 | 99.25 | 1.2292 | 1.2812 |
| SK-BR-3 | 17-AAG | 10 | uM | 7 | 156.25 | 33.46 | 67.00 | 99.25 | 0.6751 | 0.5568 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 7 | 156.25 | 33.46 | 117.00 | 99.25 | 1.1788 | 1.2212 |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 133.00 | 99.25 | 1.3401 | 1.4103 | |
| SK-BR-3 | Linsitinib | 10 | uM | 7 | 156.25 | 33.46 | 73.00 | 99.25 | 0.7355 | 0.6443 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 7 | 156.25 | 33.46 | 89.00 | 99.25 | 0.8967 | 0.8657 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 7 | 156.25 | 33.46 | 109.00 | 99.25 | 1.0982 | 1.1231 |